Similar articles for PMID: 35701204

Year	Number of Results
1958	3
1959	2
1961	1
1962	3
1964	2
2014	1
2018	1
2020	5
2021	41
2022	28
2024	0

1

COVID-19 vaccine-induced thrombotic thrombocytopenia: Adverse event associated with adenovirus vector-based vaccines.

Pottie K, Hin ANC, Saad A. Pottie K, et al. Can Fam Physician. 2022 Jun;68(6):434-437. doi: 10.46747/cfp.6806434. Can Fam Physician. 2022. PMID: 35701204 Free PMC article. English. No abstract available.

2

Restricting use of adenovirus vector-based COVID vaccines could endanger public and global health.

Ertl HCJ, Currie SL, Luber AD. Ertl HCJ, et al. Front Immunol. 2022 Aug 25;13:985382. doi: 10.3389/fimmu.2022.985382. eCollection 2022. Front Immunol. 2022. PMID: 36091063 Free PMC article. No abstract available.

3

Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19.

Jolobe OMP. Jolobe OMP. Am J Emerg Med. 2022 Apr;54:318-319. doi: 10.1016/j.ajem.2021.05.053. Epub 2021 May 23. Am J Emerg Med. 2022. PMID: 34059386 Free PMC article. No abstract available.

4

Use of adenovirus type-5 vectored vaccines: a cautionary tale.

Buchbinder SP, McElrath MJ, Dieffenbach C, Corey L. Buchbinder SP, et al. Lancet. 2020 Oct 31;396(10260):e68-e69. doi: 10.1016/S0140-6736(20)32156-5. Epub 2020 Oct 19. Lancet. 2020. PMID: 33091364 Free PMC article. No abstract available.

5

Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky.

Rubin EJ, Baden LR, Walensky RP, Morrissey S. Rubin EJ, et al. N Engl J Med. 2021 Apr 22;384(16):e73. doi: 10.1056/NEJMe2106836. N Engl J Med. 2021. PMID: 33882211 No abstract available.

6

Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination.

Haimei MA. Haimei MA. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211040110. doi: 10.1177/10760296211040110. Clin Appl Thromb Hemost. 2021. PMID: 34541935 Free PMC article. Review.

7

mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People.

Garbuglia AR, Minosse C, Del Porto P. Garbuglia AR, et al. Viruses. 2022 Apr 1;14(4):748. doi: 10.3390/v14040748. Viruses. 2022. PMID: 35458478 Free PMC article. Review.

8

Use of adenovirus type-5 vector vaccines in COVID-19: potential implications for metabolic health?

Tsilingiris D, Vallianou NG, Karampela I, Muscogiuri G, Dalamaga M. Tsilingiris D, et al. Minerva Endocrinol (Torino). 2022 Sep;47(3):264-269. doi: 10.23736/S2724-6507.22.03797-6. Epub 2022 May 27. Minerva Endocrinol (Torino). 2022. PMID: 35621112 Free article. No abstract available.

9

Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.

Tostanoski LH, Gralinski LE, Martinez DR, Schaefer A, Mahrokhian SH, Li Z, Nampanya F, Wan H, Yu J, Chang A, Liu J, McMahan K, Ventura JD, Dinnon KH, Leist SR, Baric RS, Barouch DH. Tostanoski LH, et al. J Virol. 2021 Nov 9;95(23):e0097421. doi: 10.1128/JVI.00974-21. Epub 2021 Sep 15. J Virol. 2021. PMID: 34523968 Free PMC article.

10

Spotlight on Adenovirus-Based Vaccines and Rare Thrombotic Events.

Chirumbolo S. Chirumbolo S. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211020829. doi: 10.1177/10760296211020829. Clin Appl Thromb Hemost. 2021. PMID: 34036839 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

77 results

Results by year